Logo

VolitionRx

In Brief This Week: Personalis, Biocartis, Opko Health, Berkeley Lights, More

News items for the week of Feb. 20, 2023.

VolitionRx Prices $7.5M Public Offering

Volition intends to use the proceeds for research and continued product development and clinical studies, among other things.

In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More

News items for the week of Jan. 9, 2023.

VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis

The study will use Volition's CE-marked Nu.Q NETs test to evaluate the role of neutrophil extracellular traps in cancer patients with sepsis.

VolitionRx Signs on Diagnostic Oncology CRO for Clinical Studies of Cancer, Sepsis Tests

DXOCRO will conduct large-scale clinical utility studies of Volition's Nu.Q NETs and Nu.Q Cancer tests at multiple sites in the US.

Aug 5, 2022

In Brief This Week: PreludeDx, Lucid Diagnostics, VolitionRx, CirrusDx, More

Aug 3, 2022

VolitionRx Secures $1.5M Loan From Namur Invest Capital Risk

Jul 29, 2022

VolitionRx Prices $6M Public Offering

May 13, 2022

In Brief This Week: Co-Diagnostics, Oxford Nanopore, Prenetics, Dante Labs, Seegene, More

Apr 25, 2022

VolitionRx Signs on Sage Healthcare as Distributor for Canine Cancer Test in Asia

Apr 1, 2022

In Brief This Week: Biocept, SeqLL, Castle Biosciences, VolitionRx, More

Jan 6, 2021

VolitionRx Awarded Additional $4 Million in Funding

Jan 5, 2021

VolitionRx, 4D Lifetec Partner to Combine Early Cancer Detection Assays

Jul 2, 2018

VolitionRx Receives $700K in Funding From Regional Government

May 9, 2018

VolitionRx, Active Motif Sign Global Sales, Distribution Agreement

Jan 3, 2017

VolitionRx Gets CE Mark for Colorectal Cancer Screening Test

Jun 3, 2016

VolitionRx Readying Launch of First Cancer Test Panel Using Circulating Nucelosome Technology
Premium

May 12, 2016

VolitionRx Launches Clinical Trial in Germany for Pancreatic Cancer Blood Test

Apr 7, 2016

VolitionRx Receives CE Marking for Two Colorectal Cancer Dx Assays

Sep 22, 2015

VolitionRx Receives CE Mark for Colorectal Cancer Diagnosis Assay

Mar 5, 2015

VolitionRx, ImmuneHealth Collaborate on Prostate Cancer Study

Feb 24, 2015

VolitionRx Acquires Nucleosome Analysis IP from Chroma Therapeutics

Feb 12, 2015

VolitionRx Closes Public Offering, Raises $8.5M

Feb 6, 2015

VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.